Morning Briefing
Summaries of health policy coverage from major news organizations
Studies Outline Dilemmas On New Generic Heart Drugs, HRT
One heart drug's move to generic status has complicated treatment options for some patients and doctors, the Wall Street Journal reports. Also, another study raises concerns about hormone replacement therapy in women.
This is part of the Morning Briefing, a summary of health policy coverage from major news organizations. Sign up for an email subscription.
